A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
Condition: Epilepsy Interventions: Drug: Brivaracetam; Drug: Lorazepam Sponsor: UCB Biopharma S.P.R.L. Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2017 Category: Research Source Type: clinical trials